Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127261221 | 12726122 | 1 | I | 20160723 | 20160906 | 20160908 | 20160908 | EXP | IT-MINISAL02-373520 | IT-MYLANLABS-2016M1038135 | MYLAN | 0.00 | Y | 0.00000 | 20160908 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127261221 | 12726122 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, QD | U | U | 75973 | 1000 | MG | QD | |||||
| 127261221 | 12726122 | 2 | SS | GLICLAZIDE | GLICLAZIDE | 1 | Oral | 40 MG, QD | U | U | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127261221 | 12726122 | 1 | Diabetes mellitus |
| 127261221 | 12726122 | 2 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127261221 | 12726122 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127261221 | 12726122 | Hypoglycaemic coma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127261221 | 12726122 | 1 | 20120101 | 0 | ||
| 127261221 | 12726122 | 2 | 20120101 | 0 |